AUSTIN, Texas, Dec. 03, 2024 (GLOBE NEWSWIRE) -- SoftServe, a premier IT consulting and digital services provider, today announced the debut of its newest Generative AI (Gen AI) solution, Drug Discovery, alongside its partner NVIDIA at AWS re:Invent 2024. Built with NVIDIA BioNeMo Blueprints, the reference workflows that accelerate the development and deployment of AI, SoftServe’s new solution will streamline drug development, bringing life-changing treatments to the market faster and more affordably. SoftS ...